sotorasib: Clinical Trials

68 trials of sotorasib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 16 recruiting, 7 active not recruiting, 7 terminated. 38 Phase 1, 29 Phase 2, 5 Phase 3, 1 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 138Completed 18, Recruiting 7, Terminated 5, Active not recruiting 3, Withdrawn 3, Unknown 2
Phase 229Recruiting 8, Withdrawn 5, Active not recruiting 4, Unknown 4, Completed 3, Terminated 3, Not yet recruiting 2
Phase 35Completed 2, Recruiting 2, Active not recruiting 1
Early Phase 11Recruiting 1
Phase 41Completed 1

Follow sotorasib: new trials by email Literature Review of sotorasib trials Research Report on sotorasib

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer
Adagrasib, Biospecimen Collection, Computed Tomography - Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8
Phase 2Not yet recruitingRoswell Park Cancer Institute292026-10-152026-09-02
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)372026-06-172026-09-04
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
SOC (Standard of care), Bevacizumab, Cetuximab - Dynamic Tumor Resistance, Metastatic Colorectal Cancer
Early Phase 1RecruitingM.D. Anderson Cancer Center1002026-04-222026-10-14
A 2-part Phase 1/2 Open-label Trial on ODM-212
ODM-212, Ipilimumab and nivolumab, Gemcitabine and nab-paclitaxel - Mesothelioma, Pancreatic Cancer
Phase 1 / Phase 2RecruitingOrion Corporation, Orion Pharma2292026-03-272026-11-05
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
Sotorasib, Panitumumab - Advanced Solid Tumors
Phase 2RecruitingAmgen142026-01-022026-07-23
5-fluorouracil Plus Panitumumab (Anti-EGFR) and Sotorasib (KRAS G12C Inhibitor) in First-line Treatment of Patients Non-eligible for a Doublet/Triplet Chemotherapy With Advanced Unresectab
Administration of experimental treatment association (sotorasib, panitumumab 5FU) - Colorectal Carcinoma, KRAS G12C Mutation
Phase 2Not yet recruitingFederation Francophone de Cancerologie Digestive3002025-08-312025-08-15
Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients
Sotorasib - Non-Small Cell Lung Cancer
CompletedAmgen1022025-08-112026-04-07
Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma
Sotorasib, 960 mg, oral daily dose for 4 weeks (28 days) - Pancreatic Adenocarcinoma
Phase 1RecruitingSpanish Cooperative Group for the Treatment of Digestive Tumours (TTD)152025-08-082026-04-30
AMG510 (sotorasib) Plus Lenvatinib As Second-line Treatment in Patients with KRASG12C Mutant, Metastatic NSCLC
Sotorasib, Lenvatinib - Metastatic Non Small Cell Lung Cancer, KRAS G12C
Phase 2WithdrawnETOP IBCSG Partners Foundation2025-03-012024-11-20
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
VVD-159642, Sotorasib, Trametinib - Advanced Solid Tumors
Phase 1RecruitingVividion Therapeutics, Inc.2202025-02-252026-03-18
A Study of Sotorasib in People With Brain Tumors
Sotorasib - Brain Tumor
Phase 1RecruitingMemorial Sloan Kettering Cancer Center162025-01-292026-05-22
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
Divarasib, Sotorasib, Adagrasib - Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3Active not recruitingHoffmann-La Roche3382024-09-232026-09-16
Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
Anvumetostat, Carboplatin, Paclitaxel - Thoracic Tumors, Non-small Cell Lung Cancer
Phase 1Active not recruitingAmgen492024-09-172026-05-28
A Study of Sotorasib in People With Non-Small Cell Lung Cancer
Sotorasib - Non Small Lung Cancer
Phase 2RecruitingMemorial Sloan Kettering Cancer Center392024-08-302026-09-11
ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
Alectinib, Brigatinib, Lorlatinib 100 mg - NSCLC Stage IV, Sex Disorder
UnknownFondazione Policlinico Universitario Agostino Gemelli IRCCS802024-08-052024-08-09
Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm
Phase 2Active not recruitingNational Cancer Institute (NCI)1052024-08-012026-10-22
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
FOLFIRI Regimen, Sotorasib, Panitumumab - Metastatic Colorectal Cancer
Phase 3RecruitingAmgen4502024-07-172026-09-03
A Clinical Trial to Evaluate Bioavailability and Effect of Food for Sotorasib in Healthy Participants
Sotorasib - Healthy Participants
Phase 1WithdrawnAmgen2024-07-152024-04-12
Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer
Biopsy, Biospecimen Collection, Carfilzomib - Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
Phase 1RecruitingCity of Hope Medical Center152024-04-242026-04-03
Ladarixin With Sotorasib in Advanced NSCLC - Phase II
Sotorasib, Ladarixin - Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
Phase 2WithdrawnNYU Langone Health2024-04-012024-03-29

Showing 20 of 68. Sign in to see all of them.

Conditions studied

Carcinoma, Non-Small-Cell Lung (27)  ·  Lung Neoplasms (12)  ·  Colorectal Neoplasms (5)  ·  Neoplasms (5)  ·  Neoplasm Metastasis (4)  ·  Pancreatic Neoplasms (2)  ·  Adenocarcinoma of Lung (1)  ·  Brain Neoplasms (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Endometrial Neoplasms (1)  ·  Erectile Dysfunction (1)  ·  Eunuchism (1)  ·  Fallopian Tube Neoplasms (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)

Sponsors

Amgen (27)  ·  Memorial Sloan Kettering Cancer Center (3)  ·  National Cancer Institute (NCI) (3)  ·  M.D. Anderson Cancer Center (2)  ·  NYU Langone Health (2)  ·  Allist Pharmaceuticals, Inc. (1)  ·  City of Hope Medical Center (1)  ·  Criterium, Inc. (1)  ·  Deciphera Pharmaceuticals, LLC (1)  ·  Devalingam Mahalingam (1)  ·  ETOP IBCSG Partners Foundation (1)  ·  Effector Therapeutics (1)  ·  Erasca, Inc. (1)  ·  Federation Francophone de Cancerologie Digestive (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)

Countries

United States (52)  ·  Spain (17)  ·  France (16)  ·  Italy (14)  ·  Germany (13)  ·  Australia (12)  ·  South Korea (11)  ·  Taiwan (11)  ·  Netherlands (10)  ·  Belgium (9)  ·  Greece (9)  ·  Japan (9)  ·  United Kingdom (9)  ·  Canada (8)  ·  Austria (7)

Top investigators

Salman Punekar, MD (2)  ·  Alfredo Addeo (1)  ·  Andreas N Saltos (1)  ·  Byoung Chul Cho (1)  ·  Devalingam Mahalingam, MD (1)  ·  Douglas Warner, MD (1)  ·  Ferdinandos Skoulidis, MD,PHD (1)  ·  Filippo Pietrantonio, MD (1)  ·  Grace K Dy (1)  ·  Gregory Riely, MD, PhD (1)  ·  Hossein Borghaei, DO (1)  ·  James M Ford (1)

Results publications

PMID 39604046, PMID 31820981, PMID 36546651, PMID 36764316, PMID 39752885, PMID 39777405, PMID 40333694, PMID 42814800

NIH funding

2023 (2), U10CA180820 (2), 2025 (1), P30CA033572 (1), U10CA180888 (1), UM1CA186644 (1)